Similarly, with respect to the glomerulus, individual case reports of glomerulopathies as a complication of anti–PD-1 immunotherapy exist (60, 72), though podocyte injury as assessed by foot process effacement was not common in our kidney biopsy cohort. The gene discussed is PDCD1; the disease is glomerular disorder.